Isabelle Francesca Foote
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isabelle Francesca Foote has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
- Andrew David Grotzinger
Department of Psychology and Neuroscience, University of Colorado at Boulder, Boulder, USA
5 shared publications - Michelle Luciano
Department of Psychology, University of Edinburgh, Edinburgh, UK
5 shared publications - Simon R. Cox
Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, Edinburgh, UK
5 shared publications Ania Korszun
Unit for Psychological Medicine, Wolfson Institute of Population Health, Queen Mary University of London , London EC1M 6BQ
4 shared publications- Michelle K. Lupton
Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
4 shared publications - Jeremy M. Lawrence
Department of Psychology and Neuroscience, University of Colorado at Boulder, Boulder, USA
3 shared publications
Latest Publications
- Open Access
Multi-Omic Analyses Reveal Bidirectional Genetic Links and Convergent Inflammatory-Neuronal Signatures Between Frailty, Chronic Pain, and Rheumatoid Arthritis
Background: Frailty reflects reduced physiological resilience and increased vulnerability to stressors, functioning as a key biological marker of ageing. Yet, the molecular and causal mechanisms linking frailty to chronic inflammatory conditions remain unclear. Methods: We integrate Mendelian randomisation (MR), pairwise genome-wide association (PW-GWAS), and epigenetic-protein prediction to dissect bidirectional biological pathways between frailty, chronic pain (CP), and rheumatoid arthritis (RA). Results: Across nine genetically defined frailty phenotypes - six domain-specific factors, a general frailty factor (GF), and two cumulative indices (Frailty Index - FI, Fried Frailty Score - FFS) - MR revealed widespread causal effects of CP and RA on frailty. Genetic liability to higher chronic pain robustly increased frailty severity across the cumulative frailty measures (FI and FFS) and the disability-related frailty domain (F6), with the strongest effect observed for the Frailty Index (β = 0.70, p = 7.9 x 10 -52 ), while cumulative frailty also elevated pain risk (β = 0.37, p = 2.6 x 10 -13 ), supporting a reciprocal feedback model. RA exerted more selective effects, increasing cumulative frailty (FI and FFS) and disability-related frailty (F6), whereas the general frailty factor increased RA susceptibility (OR = 4.59, p = 9.5 x 10 -8 ). Notably, the multimorbidity-related frailty domain showed an inverse effect on RA risk (OR = 0.65, p = 0.0078), suggesting immune adaptation or exhaustion within advanced frailty states. PW-GWAS and fine-mapping revealed shared causal loci linking inflammation, metabolism, and neurostructural pathways - SLC39A8 , NLGN1 , IL2RA , ERBB3 , and MAGI3 - highlighting neuroimmune and synaptic processes as convergent ageing pathways. Epigenetic-proteomic analyses further identified two opposing axes: inflammatory and complement proteins ( CRP , C5 , CCL18 , STC1 ) positively associated with frailty, versus neuronal adhesion and extracellular matrix (ECM) proteins ( NCAM1 , CNTN4 , NTRK3 , ADAMTS13 ) conferring resilience. Conclusion: Together, these findings redefine frailty as a biologically dynamic interface between inflammation and structural maintenance, where opposing molecular pathways shape vulnerability and resilience. This integrative framework highlights frailty as both a biomarker and potential intervention target, linking inflammatory dysregulation to modifiable trajectories of functional ageing.
Open AccessMulti-Omic Analyses Reveal Bidirectional Genetic Links and Convergent Inflammatory-Neuronal Signatures Between Frailty, Chronic Pain, and Rheumatoid Arthritis
Background: Frailty reflects reduced physiological resilience and increased vulnerability to stressors, functioning as a key biological marker of ageing. Yet, the molecular and causal mechanisms linking frailty to chronic inflammatory conditions remain unclear. Methods: We integrate Mendelian randomisation (MR), pairwise genome-wide association (PW-GWAS), and epigenetic-protein prediction to dissect bidirectional biological pathways between frailty, chronic pain (CP), and rheumatoid arthritis (RA). Results: Across nine genetically defined frailty phenotypes - six domain-specific factors, a general frailty factor (GF), and two cumulative indices (Frailty Index - FI, Fried Frailty Score - FFS) - MR revealed widespread causal effects of CP and RA on frailty. Genetic liability to higher chronic pain robustly increased frailty severity across the cumulative frailty measures (FI and FFS) and the disability-related frailty domain (F6), with the strongest effect observed for the Frailty Index (β = 0.70, p = 7.9 x 10 -52 ), while cumulative frailty also elevated pain risk (β = 0.37, p = 2.6 x 10 -13 ), supporting a reciprocal feedback model. RA exerted more selective effects, increasing cumulative frailty (FI and FFS) and disability-related frailty (F6), whereas the general frailty factor increased RA susceptibility (OR = 4.59, p = 9.5 x 10 -8 ). Notably, the multimorbidity-related frailty domain showed an inverse effect on RA risk (OR = 0.65, p = 0.0078), suggesting immune adaptation or exhaustion within advanced frailty states. PW-GWAS and fine-mapping revealed shared causal loci linking inflammation, metabolism, and neurostructural pathways - SLC39A8 , NLGN1 , IL2RA , ERBB3 , and MAGI3 - highlighting neuroimmune and synaptic processes as convergent ageing pathways. Epigenetic-proteomic analyses further identified two opposing axes: inflammatory and complement proteins ( CRP , C5 , CCL18 , STC1 ) positively associated with frailty, versus neuronal adhesion and extracellular matrix (ECM) proteins ( NCAM1 , CNTN4 , NTRK3 , ADAMTS13 ) conferring resilience. Conclusion: Together, these findings redefine frailty as a biologically dynamic interface between inflammation and structural maintenance, where opposing molecular pathways shape vulnerability and resilience. This integrative framework highlights frailty as both a biomarker and potential intervention target, linking inflammatory dysregulation to modifiable trajectories of functional ageing.
- Open Access
- 21 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Shared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature describes widespread psychiatric–physical comorbidity. However, the extent to which observed bivariate risk is transdiagnostic remains uncertain. We apply Genomic SEM and introduce Genomic E-SEM, an exploratory factor-analytic extension of Genomic SEM, here applied to 73 physical outcomes (~1.9 million cases) across eight medical domains. We then modeled latent physical illness factors alongside previously identified psychiatric factors. Thought/psychotic and compulsive factors exhibited few associations with physical illness factors. Conversely, internalizing, neurodevelopmental, and substance-use factors showed substantial genome-wide genetic correlations with all physical illness systems. Multivariate GWAS of a transdiagnostic physical illness factor, defined by 21 physical disorders, identified 27 genomic risk loci and exhibited substantial predictive validity in subsequent PheWAS. This transdiagnostic factor again exhibited substantial genome-wide genetic correlations with internalizing, neurodevelopmental, and substance-use factors. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and suggest the need for additional nosological frameworks.
- 21 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessShared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature describes widespread psychiatric–physical comorbidity. However, the extent to which observed bivariate risk is transdiagnostic remains uncertain. We apply Genomic SEM and introduce Genomic E-SEM, an exploratory factor-analytic extension of Genomic SEM, here applied to 73 physical outcomes (~1.9 million cases) across eight medical domains. We then modeled latent physical illness factors alongside previously identified psychiatric factors. Thought/psychotic and compulsive factors exhibited few associations with physical illness factors. Conversely, internalizing, neurodevelopmental, and substance-use factors showed substantial genome-wide genetic correlations with all physical illness systems. Multivariate GWAS of a transdiagnostic physical illness factor, defined by 21 physical disorders, identified 27 genomic risk loci and exhibited substantial predictive validity in subsequent PheWAS. This transdiagnostic factor again exhibited substantial genome-wide genetic correlations with internalizing, neurodevelopmental, and substance-use factors. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and suggest the need for additional nosological frameworks.
- Open Access
Domains of Frailty as Early Risk Factors for Alzheimer's Disease — Genetic and Causal Evidence
Background: Alzheimer's dementia (AD) is a leading cause of disability and dependency in older adults. Frailty is a phenotypic risk factor for AD, but its causal role remains unclear — partly due to reliance on composite scores that may obscure distinct mechanisms. Methods: We applied a Mendelian randomisation (MR) framework using two large GWAS of clinically diagnosed AD. Frailty exposures were derived from a multivariate genomic SEM model comprising one general factor and six domain-specific domains. Bidirectional univariable MR (UVMR) estimated total effects on AD, while multivariable MR (MVMR) adjusted for educational attainment, household income, and longevity. Results: The general frailty factor showed no evidence of a causal effect on AD. The unhealthy lifestyle frailty domain increased AD risk in UVMR (OR = 6.60, 95% CI: 2.36–18.50, q = 0.021 and OR = 3.12, 95% CI: 1.57–6.19, q = 0.001), but these effects attenuated substantially in MVMR, with betas reduced by ∼66–94% and ORs falling to ∼1.1–1.5 (non-significant), consistent with overlap with socioeconomic pathways. The disability frailty domain was nominally protective in UVMR, but positively associated with AD in MVMR (OR = 1.69, 95% CI: 1.21–2.36, q = 0.007). The poorer cognition frailty domain increased AD risk in MVMR when adjusted for education and income (OR = 1.55, 95% CI: 1.12–2.15, q = 0.025), though this effect attenuated by ∼37% with further adjustment for longevity. Sensitivity analyses indicated that this cognition–AD signal was partly driven by SNPs in SPI1, a well-established AD risk locus, consistent with pleiotropic overlap rather than an independent domain. No reverse effects were observed. Conclusions: Frailty comprises genetically distinct domains with differential causal relevance for AD. These findings highlight disability-related frailty as a potential causal contributor to AD, whereas cognitive frailty is likely predominantly driven by shared aetiology — underscoring the need to move beyond composite frailty indices when evaluating dementia risk.
Open AccessDomains of Frailty as Early Risk Factors for Alzheimer's Disease — Genetic and Causal Evidence
Background: Alzheimer's dementia (AD) is a leading cause of disability and dependency in older adults. Frailty is a phenotypic risk factor for AD, but its causal role remains unclear — partly due to reliance on composite scores that may obscure distinct mechanisms. Methods: We applied a Mendelian randomisation (MR) framework using two large GWAS of clinically diagnosed AD. Frailty exposures were derived from a multivariate genomic SEM model comprising one general factor and six domain-specific domains. Bidirectional univariable MR (UVMR) estimated total effects on AD, while multivariable MR (MVMR) adjusted for educational attainment, household income, and longevity. Results: The general frailty factor showed no evidence of a causal effect on AD. The unhealthy lifestyle frailty domain increased AD risk in UVMR (OR = 6.60, 95% CI: 2.36–18.50, q = 0.021 and OR = 3.12, 95% CI: 1.57–6.19, q = 0.001), but these effects attenuated substantially in MVMR, with betas reduced by ∼66–94% and ORs falling to ∼1.1–1.5 (non-significant), consistent with overlap with socioeconomic pathways. The disability frailty domain was nominally protective in UVMR, but positively associated with AD in MVMR (OR = 1.69, 95% CI: 1.21–2.36, q = 0.007). The poorer cognition frailty domain increased AD risk in MVMR when adjusted for education and income (OR = 1.55, 95% CI: 1.12–2.15, q = 0.025), though this effect attenuated by ∼37% with further adjustment for longevity. Sensitivity analyses indicated that this cognition–AD signal was partly driven by SNPs in SPI1, a well-established AD risk locus, consistent with pleiotropic overlap rather than an independent domain. No reverse effects were observed. Conclusions: Frailty comprises genetically distinct domains with differential causal relevance for AD. These findings highlight disability-related frailty as a potential causal contributor to AD, whereas cognitive frailty is likely predominantly driven by shared aetiology — underscoring the need to move beyond composite frailty indices when evaluating dementia risk.
- Open Access
- 4 August 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (8) , 1848-1859
Uncovering the multivariate genetic architecture of frailty with genomic structural equation modeling
Frailty is a multifaceted clinical state associated with accelerated aging and adverse health outcomes. Informed etiological models of frailty hold promise for producing widespread health improvements across the aging population. Frailty is currently measured using aggregate scores, which obscure etiological pathways that are only relevant to subcomponents of frailty. Here we perform a multivariate genome-wide association study of the latent genetic architecture between 30 frailty deficits, which identifies 408 genomic risk loci. Our model includes a general factor of genetic overlap across all deficits, plus six new factors indexing a shared genetic signal across specific groups of deficits. We demonstrate the added clinical and etiological value of the six factors, including predicting frailty in external datasets, highlighting divergent genetic correlations with clinically relevant outcomes and uncovering unique underlying biology linked to aging. We show that nuanced models of frailty are key to understanding its causes and how it relates to worse health.
- 4 August 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (8) , 1848-1859
Open AccessUncovering the multivariate genetic architecture of frailty with genomic structural equation modeling
Frailty is a multifaceted clinical state associated with accelerated aging and adverse health outcomes. Informed etiological models of frailty hold promise for producing widespread health improvements across the aging population. Frailty is currently measured using aggregate scores, which obscure etiological pathways that are only relevant to subcomponents of frailty. Here we perform a multivariate genome-wide association study of the latent genetic architecture between 30 frailty deficits, which identifies 408 genomic risk loci. Our model includes a general factor of genetic overlap across all deficits, plus six new factors indexing a shared genetic signal across specific groups of deficits. We demonstrate the added clinical and etiological value of the six factors, including predicting frailty in external datasets, highlighting divergent genetic correlations with clinically relevant outcomes and uncovering unique underlying biology linked to aging. We show that nuanced models of frailty are key to understanding its causes and how it relates to worse health.
- Open Access
- 21 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Measurement characteristics and genome-wide correlates of lifetime brain atrophy estimated from a single MRI
As a cardinal marker of brain ageing, lifetime brain atrophy obtained from a cross-sectional magnetic resonance image promises to boost statistical power to uncover novel genetic mechanisms of neurodegeneration. By analysing five young and old adult cohorts, we perform the most definitive study on lifetime brain atrophy’s measurement and correlates. It is simply calculated from the relationship between total brain volume and intracranial volume, using the difference, ratio, or regression-residual method. Lifetime brain atrophy is correlated with well-validated neuroradiological atrophy ratings (r = 0.37–0.44), cognitive decline (r = 0.36), frailty (r = 0.24), and longitudinally-measured atrophic changes (r = 0.36). Lifetime brain atrophy computed with the difference method yields phenotypic and genetic signal similar to baseline intracranial volume (r g = 0.75), in contrast to the residual method, which also best captures brain shrinkage. Lifetime brain atrophy is highly heritable (h 2 SNP = 41%[95%CI = 38–43%]), and the strongest genome-wide association (N = 43,110) implicates WNT16, a gene linked with neurodegenerative diseases.
- 21 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessMeasurement characteristics and genome-wide correlates of lifetime brain atrophy estimated from a single MRI
As a cardinal marker of brain ageing, lifetime brain atrophy obtained from a cross-sectional magnetic resonance image promises to boost statistical power to uncover novel genetic mechanisms of neurodegeneration. By analysing five young and old adult cohorts, we perform the most definitive study on lifetime brain atrophy’s measurement and correlates. It is simply calculated from the relationship between total brain volume and intracranial volume, using the difference, ratio, or regression-residual method. Lifetime brain atrophy is correlated with well-validated neuroradiological atrophy ratings (r = 0.37–0.44), cognitive decline (r = 0.36), frailty (r = 0.24), and longitudinally-measured atrophic changes (r = 0.36). Lifetime brain atrophy computed with the difference method yields phenotypic and genetic signal similar to baseline intracranial volume (r g = 0.75), in contrast to the residual method, which also best captures brain shrinkage. Lifetime brain atrophy is highly heritable (h 2 SNP = 41%[95%CI = 38–43%]), and the strongest genome-wide association (N = 43,110) implicates WNT16, a gene linked with neurodegenerative diseases.
- Open Access
- 4 March 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (2) , fcaf112
Examining the genetic relationship between Alzheimer’s disease, schizophrenia and their shared risk factors using genomic structural equation modelling
Epidemiological studies have demonstrated an association between dementia and schizophrenia. There is a significant symptom overlap between the two disorders—psychosis is seen in 50% of patients with Alzheimer’s disease and cognitive impairment is a key feature of schizophrenia. Whether these overlapping clinical presentations reflect shared aetiology is unclear. Therefore, we aimed to model the genetic correlation between Alzheimer’s disease, schizophrenia and their shared risk factors using genomic structural equation modelling to identify potentially overlapping biological pathways between these traits. We measured genetic correlation between Alzheimer’s disease, schizophrenia and 13 shared risk factors, including body fat percentage, less education, alcohol intake, insomnia, loneliness, less social/leisure activity, major depression, mean arterial pressure, smoking, socioeconomic deprivation, low-density lipoprotein cholesterol, eye problems and type 2 diabetes mellitus. Schizophrenia and Alzheimer’s disease were not significantly genetically correlated but were both significantly associated with loneliness. Colocalization suggested that the association between loneliness and Alzheimer’s disease was predominantly driven by a shared causal variant on Chromosome 11. Factor analysis of shared risk factors produced four latent factors representing clusters of shared genetics between socioeconomic traits, psychiatric traits, cardiometabolic traits and smoking-related traits. Both Alzheimer’s disease and schizophrenia were significantly associated with the socioeconomic latent factor. Although there is little direct genetic overlap between schizophrenia and Alzheimer’s disease, loneliness may play an important role in the association between these two disorders. In addition, the shared genetics between socioeconomic traits may affect susceptibility to both Alzheimer’s disease and schizophrenia to a greater extent than trait-specific pathways.
- 4 March 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (2) , fcaf112
Open AccessExamining the genetic relationship between Alzheimer’s disease, schizophrenia and their shared risk factors using genomic structural equation modelling
Epidemiological studies have demonstrated an association between dementia and schizophrenia. There is a significant symptom overlap between the two disorders—psychosis is seen in 50% of patients with Alzheimer’s disease and cognitive impairment is a key feature of schizophrenia. Whether these overlapping clinical presentations reflect shared aetiology is unclear. Therefore, we aimed to model the genetic correlation between Alzheimer’s disease, schizophrenia and their shared risk factors using genomic structural equation modelling to identify potentially overlapping biological pathways between these traits. We measured genetic correlation between Alzheimer’s disease, schizophrenia and 13 shared risk factors, including body fat percentage, less education, alcohol intake, insomnia, loneliness, less social/leisure activity, major depression, mean arterial pressure, smoking, socioeconomic deprivation, low-density lipoprotein cholesterol, eye problems and type 2 diabetes mellitus. Schizophrenia and Alzheimer’s disease were not significantly genetically correlated but were both significantly associated with loneliness. Colocalization suggested that the association between loneliness and Alzheimer’s disease was predominantly driven by a shared causal variant on Chromosome 11. Factor analysis of shared risk factors produced four latent factors representing clusters of shared genetics between socioeconomic traits, psychiatric traits, cardiometabolic traits and smoking-related traits. Both Alzheimer’s disease and schizophrenia were significantly associated with the socioeconomic latent factor. Although there is little direct genetic overlap between schizophrenia and Alzheimer’s disease, loneliness may play an important role in the association between these two disorders. In addition, the shared genetics between socioeconomic traits may affect susceptibility to both Alzheimer’s disease and schizophrenia to a greater extent than trait-specific pathways.
- Open Access
- 20 December 2024
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 5 (12) , 100665
Next generation brain health: transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations
- 20 December 2024
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 5 (12) , 100665
Open AccessNext generation brain health: transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Multivariate genomic analyses of frailty reveal the unique importance of cognitive and multimorbidity pathways for aging‐related health outcomes
Background: Frailty is a complex clinical state that is associated with poorer health outcomes and increased dementia risk in older adults. It is routinely measured using the Frailty Index, which is a proportional score based on the number of ‘deficits’ that an individual has. Whilst such measures are useful for risk assessment, the aggregation of highly heterogeneous deficit profiles in genetic studies may obscure important insights into the underlying biology of frailty.Method: We used Genomic Structural Equation Modelling to model shared genetic signal between 30 deficits from the Frailty Index using summary data from genome‐wide association studies (GWAS). This involved conducting a multivariate GWAS to identify genomic risk loci associated with each of the latent frailty factors in our model. We used polygenic risk scores (PRS) to test the predictive accuracy of the latent factors for detecting frailty status in 3 external cohort studies. Finally, we tested the genetic correlation between our latent frailty factors and >50 aging‐related outcomes, including dementia.Result: The genetic architecture of the frailty deficits was best captured by a general factor influencing all 30 deficits, plus 6 additional latent factors representing genetic overlap between distinct subsets of deficits that were uncorrelated with the general factor. These 6 factors can be broadly described as reflecting pathways linked to social isolation, unhealthy lifestyle, multimorbidity, metabolic/respiratory status, cognition, and disability. GWAS conducted to measure the effects of individual genetic variants on these frailty factors identified 408 genomic risk loci. Our PRS analyses demonstrated consistent evidence that shared genetic pathways between frailty deficits linked to multimorbidity and cognition, but unique of the general frailty factor, are particularly important for predicting frailty status. Genetic correlation analyses further highlighted a significant genetic association between frailty pathways linked to cognition and Alzheimer’s disease (rg = 0.32, SE = 0.07, p = 5.58×10−06).Conclusion: Our findings provide novel insights into the characterization of general and specific pathways within the frailty state at the genetic level. We demonstrate how refining our knowledge of frailty, particularly in relation to multimorbidity and cognitive impairment, may help to stratify frail individuals at increased risk of developing dementia or other adverse health outcomes.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Open AccessMultivariate genomic analyses of frailty reveal the unique importance of cognitive and multimorbidity pathways for aging‐related health outcomes
Background: Frailty is a complex clinical state that is associated with poorer health outcomes and increased dementia risk in older adults. It is routinely measured using the Frailty Index, which is a proportional score based on the number of ‘deficits’ that an individual has. Whilst such measures are useful for risk assessment, the aggregation of highly heterogeneous deficit profiles in genetic studies may obscure important insights into the underlying biology of frailty.Method: We used Genomic Structural Equation Modelling to model shared genetic signal between 30 deficits from the Frailty Index using summary data from genome‐wide association studies (GWAS). This involved conducting a multivariate GWAS to identify genomic risk loci associated with each of the latent frailty factors in our model. We used polygenic risk scores (PRS) to test the predictive accuracy of the latent factors for detecting frailty status in 3 external cohort studies. Finally, we tested the genetic correlation between our latent frailty factors and >50 aging‐related outcomes, including dementia.Result: The genetic architecture of the frailty deficits was best captured by a general factor influencing all 30 deficits, plus 6 additional latent factors representing genetic overlap between distinct subsets of deficits that were uncorrelated with the general factor. These 6 factors can be broadly described as reflecting pathways linked to social isolation, unhealthy lifestyle, multimorbidity, metabolic/respiratory status, cognition, and disability. GWAS conducted to measure the effects of individual genetic variants on these frailty factors identified 408 genomic risk loci. Our PRS analyses demonstrated consistent evidence that shared genetic pathways between frailty deficits linked to multimorbidity and cognition, but unique of the general frailty factor, are particularly important for predicting frailty status. Genetic correlation analyses further highlighted a significant genetic association between frailty pathways linked to cognition and Alzheimer’s disease (rg = 0.32, SE = 0.07, p = 5.58×10−06).Conclusion: Our findings provide novel insights into the characterization of general and specific pathways within the frailty state at the genetic level. We demonstrate how refining our knowledge of frailty, particularly in relation to multimorbidity and cognitive impairment, may help to stratify frail individuals at increased risk of developing dementia or other adverse health outcomes.
- Open Access
Shared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature has shown that there are extensive comorbidity patterns between psychiatric and physical illness. However, our understanding of the multivariate systems of relationships underlying these patterns is poorly understood. Using Genomic SEM and Genomic E-SEM, an extension for genomic exploratory factor analysis that we introduce and validate, we evaluate the extent to which latent genomic factors from eight domains, encompassing 76 physical outcomes across 1.9 million cases, evince genetic overlap with previously identified psychiatric factors. We find that internalizing, neurodevelopmental, and substance use factors are broadly associated with increased genetic risk sharing across all physical illness domains. Conversely, we find that a compulsive factor is protective against circulatory and metabolic illness, whereas genetic risk sharing between physical illness factors and psychotic/thought disorders was limited. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and call into question the bifurcation of psychiatric and physical conditions.
Open AccessShared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature has shown that there are extensive comorbidity patterns between psychiatric and physical illness. However, our understanding of the multivariate systems of relationships underlying these patterns is poorly understood. Using Genomic SEM and Genomic E-SEM, an extension for genomic exploratory factor analysis that we introduce and validate, we evaluate the extent to which latent genomic factors from eight domains, encompassing 76 physical outcomes across 1.9 million cases, evince genetic overlap with previously identified psychiatric factors. We find that internalizing, neurodevelopmental, and substance use factors are broadly associated with increased genetic risk sharing across all physical illness domains. Conversely, we find that a compulsive factor is protective against circulatory and metabolic illness, whereas genetic risk sharing between physical illness factors and psychotic/thought disorders was limited. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and call into question the bifurcation of psychiatric and physical conditions.